MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
By Galina Gabriely, T. Wurdinger, S. Kesari, Christine Esau, J. Burchard, Peter S. Linsley, Anna M. Krichevsky. Molecular and Cellular Biology, 2008
926 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/ffbea4a6490dcb9e3cf06bfb5ffb0d4c9b12e5a1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- George A. Calin
- Danish H Sayed
- M. Abdellatif
- Galina Gabriely
- M. Shimizu
- Anna M. Krichevsky
- Simona Rossi
- Carlo Maria Croce
In Molecular Biology
- George A. Calin
- Danish H Sayed
- M. Abdellatif
- Galina Gabriely
- M. Shimizu
- Simona Rossi
- Anna M. Krichevsky
- Carlo Maria Croce
Citations in the corpus
- MicroRNAs in development and disease. (2011, background): “It targets the metalloproteinase (MMP) inhibitors, reversion-inducing-cysteine-rich protein with kazal motifs (RECK) and tissue inhibitor of metalloproteinase-3 (TIMP3) and, thus, activates MMPs and facilitates cell motility and metastasis both in vitro and in vivo (192).”
- MicroRNAs — the micro steering wheel of tumour metastases (2009, methodology): “In fact, miR-21 was found to stimulate cell invasion and metastasis in different tumour models (breast cancer, colon cancer and gliomas) using similar in vitro and in vivo assay”
- miR-21: a small multi-faceted RNA (2008, methodology): “Several computational algorithms predict hundreds of mRNAs as possible targets for miR-21 [55–57 [49, 53] and proteomics [58], each with certain advantages and flaws, have been used after cell treatments with anti-miR-21.”